Neurologic complications of leukemia

Cancer Neurology In Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition

Volumn , Issue , 2008, Pages 555-565

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

leptomeningeal metastases; leukemia; meningitis; neurologic complications

Indexed keywords

EID: 77950158410     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-412-4_29     Document Type: Chapter

References (55)

1. Xie Y, Davies SM, Xiang Y et al. Trends in leukemia incidence and survival in the United States (1973-1998); Cancer 2004 (97) 9:2229-2235.
2. Hoelzer D, Gokbuget N, Ottmann O et al. Acute lymphoblastic leukemia. Hematology 2002 (1): 162-171.
3. Pui C-H, Evans WE. Acute lymphoblastic leukemia. Drug Therapy (339) 9:605-615.
4. Recht L, Mrugala M. Neurologic complications of hematologic neoplasms. Neurol Clin N Am. 2003 (21):87-105.
5. Meyer RJ, Ferreira, PP, Cuttner J et al. Central nervous system involvement at presentation in acute granulocytic leukemia: a prospective cytocentrifuge study. Am J Med 1980; 68:691-694.
6. Teshima T, Akashi K, Shibuka T et al. Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer 1990; 65:327-332.
7. Kim H, Lee J-H, Choi S-J et al. Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 2004; 89:622-624.
8. Kawanami T, Kurita K, Yamakawa M et al. Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients. Intern Med. 2002; 41(12): 1130-1134.
9. Sostak P, Padovan CS, Yousry TA et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003; 60:842-848.
10. Bower JH, Hammack JE, McDonnell SK et al. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997; 48:407-412.
11. Cramer SC, Glaspy JA, Efird JT et al. Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 1996; 46:19-25.
12. Plotkin SR, Wen PY. Neurologic complications of cancer therapy. Neurol Clin N Am 2003; 21:279-318.
13. Cortes J. Central nervous system involvement in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2001; 15:145-162.
14. Wolk RW, Masse SR, Conklin R, Freireich EJ. The incidence of central nervous system leukemia in adults with acute leukemia. Cancer 1974; 33:863-871.
15. Stewart DJ, Keating MJ, McCredie KB et al. Natural history of central nervous system acute leukemia in adults. Cancer 1981; 47:184-196.
16. Chen C-Y, Zimmerman RA, Faro S et al. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR 1996; 17:295-310.
17. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.
18. Shin RK, Stern JW, Janss AJ et al. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001; 56:388-391.
19. Lavigne CM, Shrier DA, Ketkar M t al. Tacrolimus leukoencephalopathy: a neuropathological confirmation. Neurology 2004; 2: 1132-1133.
20. Lamy C, Oppenheim C, Meder JF et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004; 14:89-96.
21. Anders KH, Becker SP, Holden JK et al. Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases. Hum Pathol 1993; 24(8):897-904.
22. Surapaneni UR, Cortes JE, Thomas D et al. Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer 2002; 94 (3):773-780.
23. Cash J, Fehir KM, Pollack MS. Meningeal involvement in early stage chronic lymphocytic leukemia. Cancer 1987; 59:798-800.
24. Dekker AW, Elderson A, Punt K et al. Meningeal involvement in patients with acute nonlymphocytic leukemia. Cancer 1985; 56:2078-2082.
25. Kaplan JG, DeSouza TG, Farkash A et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas, and leukemias. J Neuro Oncol 1990; 9:225-229.
26. Chamberlain M. Leptomeningeal metastases. In: Cancer in the Nervous System. Levin V (ed.). New York: Churchill Livingstone, 1996:282-290.
27. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999; 25(2): 103-119.
28. Chamberlain MC. Leptomeningeal metastases: a review of evaluation and treatment. J Neuro Oncol 1998; 37:271-284.
29. Kantarjian HM, Walters RS, Smith TL et al. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood 1988; 72:1784-1789.
30. Kantarjian HM, Smith T, Estey E et al. Prognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia. Am J Med. 1992; 93:599-604.
31. Ravandi F, Cortes J, Estrov Z et al. CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res. 2002; 26:643-649.
32. Kantarijian HM, O'Brien S, Smith TL et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult a cute lymphocytic leukemia. J Clin Oncol. 2000; 18:547-561.
33. Mavlight GM, Stuckey SE, Cabanillas FF et al. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med. 1980; 303:718-722.
34. Kersten MJ, Evers LM, Dellemijn PL et al. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 1996; 87:1985-1999.
35. Burger B, Zimmermann M, Mann G et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003; 21 (2): 184-188.
36. Wasserstrom W, Glass J, Posner J. Diagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients. Cancer 1982, 49:759-772.
37. Van Oostenbrugge RJ, Twijnstra A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999; 53:382-385.
38. Wasserstrom WR, Schwartz MK, Fleisher M et al. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 1981; 11 (3): 239-251.
39. Van Zanten AP, Twijnstra A, Hart AA et al. Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta 1986; 161(3):259-268.
40. Klee GG, Tallman RD, Goellner JR et al. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986; 61(1):9-13.
41. Twijnstra A, van Zanten AP, Hart AA et al. Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 1987; 50(3):313-320.
42. Twijnstra A, Ongerboer dV, van Zanten AP et al. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neuro Oncol 1989; 7(1):57-63.
43. Chamberlain MC. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998; 50(4): 1173-1175.
44. Garson JA, Coakham HB, Kemshead JT et al. The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neuro Oncol 1985; 3(2): 165-171.
45. Boogerd W, Vroom TM, van Heerde P et al. CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 1988; 51(1):142-145.
46. Van Oostenbrugge RJ, Hopman AH, Ramaekers FC et al. In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis. JNeuro Oncol 1998; 38 (2-3):127-133.
47. Cibas ES, Malkin MG, Posner JB et al. Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987; 88(5):570-577.
48. Biesterfeld S, Bernhard B, Bamborschke S et al. DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 1993; 86(5):428-432.
49. Van Oostenbrugge RJ, Hopman AH, Arends JW et al. The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 1998; 51(3):906-908.
50. Chamberlain M, Sandy A, Press G. Leptomeningeal metastasis a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 1990, 40:435-438.
51. Gomori JM, Heching N, Siegal T. Leptomeningeal metastases: evaluation by gadolinium-enhanced spinal magnetic resonance imaging. J Neuro Oncol 1998; 36:55-60.
52. Sze G, Soletsky S, Bronen R et al. MR Imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis. AJNR 1989; 10:965-975.
53. Chamberlain MC. Comparative spine imaging in leptomeningeal metastases. Neurooncol 1995; 23:233-238.
54. Kramer E, Rafto S, Packer R et al. Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 1991; 41:46-50.
55. Chamberlain M, Corey-Bloom J. Leptomeningeal metastases indium-DTPA CSF flow studies. Neurology 1991; 41:1765-1769.